Research programme: Nav1.7 gain of function mutation diagnostics - Biogen
Latest Information Update: 28 Jul 2018
At a glance
- Originator Convergence Pharmaceuticals
- Developer Biogen; Yale University
- Class Diagnostic agents
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Neuropathic pain
Most Recent Events
- 28 Jul 2018 No recent reports of development identified for clinical-Phase-Unknown development in Neuropathic-pain(Diagnosis) in USA
- 06 Oct 2014 Clinical trials in Neuropathic pain (Diagnosis) in USA (unspecified route)